<https://rdf.molmedb.upol.cz/reference/ref1316> <http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2015.12.071"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM490780>,
		<https://identifiers.org/molmedb/MM17106>;
	<http://purl.org/ontology/bibo/pmid> "26748694"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM494027>;
	<http://purl.org/dc/terms/bibliographicCitation> "Éliás O, Nógrádi K, Domány G, Szakács Z, Kóti J, Szántay C, Tarcsay Á, Keserű GM, Gere A, Kiss B, Kurkó D, Kolok S, Némethy Z, Kapui Z, Hellinger É, Vastag M, Sághy K, Kedves R, Gyertyán I.: The influence of 5-HT(2A) activity on a 5-HT(2C) specific in vivo assay used for early identification of multiple acting SERT and 5-HT(2C) receptor ligands. Bioorg Med Chem Lett, Volume 26 (3), 2016"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM494026>,
		<https://rdf.molmedb.upol.cz/interaction/membrane21>,
		<https://rdf.molmedb.upol.cz/transporter/target86> .
<https://rdf.molmedb.upol.cz/interaction/int1031233> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1316> .
<https://rdf.molmedb.upol.cz/interaction/int1024555> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1316> .
<https://rdf.molmedb.upol.cz/interaction/int1031231> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1316> .
<https://rdf.molmedb.upol.cz/transporter/tra31605> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1316> .